Abstract
Myxofibrosarcoma is an aggressive soft tissue neoplasm that is classified as a type of malignant fibrohistiocytic tumor. The combination of PET and MR imaging is helpful in determining the extent of local infiltration, defining surgical margins, and detection of small satellite lesions. PET/MRI is also useful in monitoring patients’ response to local and systemic therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Ioannidis JP, Lau J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med. 2003;44:717–24.
Kaya M, Wada T, Nagoya S, Sasaki M, Matsumura T, Yamaguchi T, et al. MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skelet Radiol. 2008;37:1085–90.
Kikuta K, Kubota D, Yoshida A, Morioka H, Toyama Y, Chuuman H, et al. An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI. Skelet Radiol. 2015;44:55–62.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Gupta, R. (2018). Malignant Soft Tissue Myxofibrosarcoma. In: PET/MR Imaging . Springer, Cham. https://doi.org/10.1007/978-3-319-65106-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-65106-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65105-7
Online ISBN: 978-3-319-65106-4
eBook Packages: MedicineMedicine (R0)